|
1
|
Bailey ST, Westerling T and Brown M: Loss
of estrogen-regulated microRNA expression increases HER2 signaling
and is prognostic of poor outcome in luminal breast cancer. Cancer
Res. 75:436–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen R, Zhou X, Liu J and Huang G:
Relationship between 18F-FDG PET/CT findings and HER2 expression in
gastric cancer. J Nucl Med. 57:1040–1044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Darb-Esfahani S, Denkert C, Stenzinger A,
Salat C, Sinn B, Schem C, Endris V, Klare P, Schmitt W, Blohmer JU,
et al: Role of TP53 mutations in triple negative and HER2-positive
breast cancer treated with neoadjuvant anthracycline/taxane-based
chemotherapy. Oncotarget. 7:67686–67698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Martino M, Forzati F, Marfella M,
Pellecchia S, Arra C, Terracciano L, Fusco A and Esposito F:
HMGA1P7-pseudogene regulates H19 and Igf2 expression by a
competitive endogenous RNA mechanism. Sci Rep. 6:376222016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Degrauwe N, Suvà ML, Janiszewska M, Riggi
N and Stamenkovic I: IMPs: An RNA-binding protein family that
provides a link between stem cell maintenance in normal development
and cancer. Genes Dev. 30:2459–2474. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ,
Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, et al: The H19/let-7
double-negative feedback loop contributes to glucose metabolism in
muscle cells. Nucleic Acids Res. 42:13799–13811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Wang H, Yao B, Xu W, Chen J and Zhou
X: lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by
targeting VDAC1 in diabetic cardiomyopathy. Sci Rep. 6:363402016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang WC, Fu WM, Wang YB, Sun YX, Xu LL,
Wong CW, Chan KM, Li G, Waye MM and Zhang JF: H19 activates Wnt
signaling and promotes osteoblast differentiation by functioning as
a competing endogenous RNA. Sci Rep. 6:201212016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao P, Zhang C, Bian X, Guo Y, Wei Y,
Zhang L, Liu Z, Wang X and Huang S: The increasingly anti-tumor
effect of a colonic carcinoma DNA vaccine carrying HER2 by the
adjuvanticity of IL-12. Immunopharmacol Immunotoxicol. 1–6.
2016.(Epub ahead of print). PubMed/NCBI
|
|
14
|
Hanna MG, Bleiweiss IJ, Nayak A and Jaffer
S: Correlation of Oncotype DX recurrence score with histomorphology
and immunohistochemistry in over 500 patients. Int J Breast Cancer.
2017:12570782017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lambein K, Van Bockstal M, Vandemaele L,
Geenen S, Rottiers I, Nuyts A, Matthys B, Praet M, Denys H and
Libbrecht L: Distinguishing score 0 from score 1+ in HER2
immunohistochemistry-negative breast cancer: Clinical and
pathobiological relevance. Am J Clin Pathol. 140:561–566. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meller S, Meyer HA, Bethan B, Dietrich D,
Maldonado SG, Lein M, Montani M, Reszka R, Schatz P, Peter E, et
al: Integration of tissue metabolomics, transcriptomics and
immunohistochemistry reveals ERG- and gleason score-specific
metabolomic alterations in prostate cancer. Oncotarget.
7:1421–1438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seyed Jafari SM and Hunger RE: IHC optical
density score: A new practical method for quantitative
immunohistochemistry image analysis. Appl Immunohistochem Mol
Morphol. 25:e12–e13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Viúdez A, Carvalho FL, Maleki Z, Zahurak
M, Laheru D, Stark A, Azad NS, Wolfgang CL, Baylin S, Herman JG and
De Jesus-Acosta A: A new immunohistochemistry prognostic score
(IPS) for recurrence and survival in resected pancreatic
neuroendocrine tumors (PanNET). Oncotarget. 7:24950–24961. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Viudez A, Carvalho FL, Maleki Z, Zahurak
M, Laheru D, Stark A, Azad NS, Wolfgang CL, Baylin S, Herman JG and
De Jesus-Acosta A: Correction: A new immunohistochemistry
prognostic score (IPS) for recurrence and survival in resected
pancreatic neuroendocrine tumors (PanNET). Oncotarget.
8:186172017.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu C, Chen Z, Fang J, Xu A, Zhang W and
Wang Z: H19-derived miR-675 contributes to bladder cancer cell
proliferation by regulating p53 activation. Tumour Biol.
37:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herrera-Marcos LV, Lou-Bonafonte JM, Arnal
C, Navarro MA and Osada J: Transcriptomics and the mediterranean
diet: A systematic review. Nutrients. 9:E4722017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu C, Zhang YH, Deng Q, Li Y, Huang T,
Zhou S and Cai YD: Cancer-Related Triplets of mRNA-lncRNA-miRNA
revealed by integrative network in uterine corpus endometrial
carcinoma. Biomed Res Int. 2017:38595822017.PubMed/NCBI
|
|
24
|
Mao Y, Liu R, Zhou H, Yin S, Zhao Q, Ding
X and Wang H: Transcriptome analysis of miRNA-lncRNA-mRNA
interactions in the malignant transformation process of gastric
cancer initiation. Cancer Gene Ther. 24:267–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu Q, Guo L, Jiang F, Li L, Li Z and Chen
F: Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER-breast
cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yao K, Wang Q, Jia J and Zhao H: A
competing endogenous RNA network identifies novel mRNA, miRNA and
lncRNA markers for the prognosis of diabetic pancreatic cancer.
Tumour Biol. 39:10104283177078822017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ye S, Yang L, Zhao X, Song W, Wang W and
Zheng S: Bioinformatics method to predict two regulation mechanism:
TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Cell
Biochem Biophys. 70:1849–1858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai H, Yao J, An Y, Chen X, Chen W, Wu D,
Luo B, Yang Y, Jiang Y, Sun D and He X: lncRNA HOTAIR acts a
competing endogenous RNA to control the expression of notch3 via
sponging miR-613 in pancreatic cancer. Oncotarget. 8:32905–32917.
2017.PubMed/NCBI
|
|
29
|
Keniry A, Oxley D, Monnier P, Kyba M,
Dandolo L, Smits G and Reik W: The H19 lincRNA is a developmental
reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell
Biol. 14:659–665. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin LT, Chang CY, Chang CH, Wang HE, Chiou
SH, Liu RS, Lee TW and Lee YJ: Involvement of let-7 microRNA for
the therapeutic effects of Rhenium-188-embedded liposomal
nanoparticles on orthotopic human head and neck cancer model.
Oncotarget. 7:65782–65796. 2016.PubMed/NCBI
|
|
31
|
Lodewijk L, Prins AM, Kist JW, Valk GD,
Kranenburg O, Rinkes IH and Vriens MR: The value of miRNA in
diagnosing thyroid cancer: A systematic review. Cancer Biomark.
11:229–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Srivastava K and Srivastava A:
Comprehensive review of genetic association studies and
meta-analyses on miRNA polymorphisms and cancer risk. PLoS One.
7:e509662012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tilghman SL, Rhodes LV, Bratton MR,
Carriere P, Preyan LC, Boue SM, Vasaitis TS, McLachlan JA and Burow
ME: Phytoalexins, miRNAs and breast cancer: A review of
phytochemical-mediated miRNA regulation in breast cancer. J Health
Care Poor Underserved. 24 Suppl 1:S36–S46. 2013. View Article : Google Scholar
|
|
34
|
Wang QX, Zhu YQ, Zhang H and Xiao J:
Altered miRNA expression in gastric cancer: A systematic review and
meta-analysis. Cell Physiol Biochem. 35:933–944. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu X, Yang X, Xing C, Zhang S and Cao J:
miRNA: The nemesis of gastric cancer (Review). Oncol Lett.
6:631–641. 2013.PubMed/NCBI
|
|
36
|
Zhao Y, Deng C, Wang J, Xiao J, Gatalica
Z, Recker RR and Xiao GG: Let-7 family miRNAs regulate estrogen
receptor alpha signaling in estrogen receptor positive breast
cancer. Breast Cancer Res Treat. 127:69–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nonagase Y, Yonesaka K, Kawakami H,
Watanabe S, Haratani K, Takahama T, Takegawa N, Ueda H, Tanizaki J,
Hayashi H, et al: Heregulin-expressing HER2-positive breast and
gastric cancer exhibited heterogeneous susceptibility to the
anti-HER2 agents lapatinib, trastuzumab and T-DM1. Oncotarget.
7:84860–84871. 2016.PubMed/NCBI
|
|
38
|
Ohtsuka M, Ling H, Ivan C, Pichler M,
Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X,
Chen M, et al: H19 noncoding RNA, an independent prognostic factor,
regulates essential Rb-E2F and CDK8-β-catenin signaling in
colorectal cancer. EBioMedicine. 13:113–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peng F, Li TT, Wang KL, Xiao GQ, Wang JH,
Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, et al: H19/let-7/LIN28
reciprocal negative regulatory circuit promotes breast cancer stem
cell maintenance. Cell Death Dis. 8:e25692017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ravid O, Shoshani O, Sela M, Weinstock A,
Sadan TW, Gur E, Zipori D and Shani N: Relative genomic stability
of adipose tissue derived mesenchymal stem cells: Analysis of
ploidy, H19 long non-coding RNA and p53 activity. Stem Cell Res
Ther. 5:1392014. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reese KJ, Lin S, Verona RI, Schultz RM and
Bartolomei MS: Maintenance of paternal methylation and repression
of the imprinted H19 gene requires MBD3. PLoS Genet. 3:e1372007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Scrima M, Zito Marino F, Oliveira DM,
Marinaro C, La Mantia E, Rocco G, De Marco C, Malanga D, De Rosa N,
Rizzuto A, et al: Aberrant signaling through the HER2-ERK1/2
pathway is predictive of reduced disease-free and overall survival
in early stage non-small cell lung cancer (NSCLC) patients. J
Cancer. 8:227–239. 2017. View Article : Google Scholar : PubMed/NCBI
|
